Alex Goldberg

Hudson City Bancorp, Inc. (NASDAQ:HCBK) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/26/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Hudson City Bancorp, Inc. (NASDAQ:HCBK) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Hudson City Bancorp, Inc. (NASDAQ:HCBK) operates as the holding company of Hudson City Savings Bank that provides various banking products and services in the United States is currently up (+0.21%) on 792,133 shares traded. Hudson City Bancorp, Inc. (NASDAQ:HCBK) is currently up (+22.43%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Hudson City Bancorp, Inc. (NASDAQ:HCBK)

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a company that engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases is currently up (+0.38%) on 412,491 shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is currently up (+83.54%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com